Merck (MRK) Accumulated Depreciation & Amortization (2009 - 2025)
Merck (MRK) reported Accumulated Depreciation & Amortization of $21.9 billion for Q4 2025, up 14.4% year-over-year from $19.2 billion in Q4 2024, and up 14.4% on a QoQ basis from $19.2 billion in Q4 2024.
Merck (MRK) has 17 years of Accumulated Depreciation & Amortization data on file, last reported at $21.9 billion in Q4 2025.
- Quarterly Accumulated Depreciation & Amortization rose 14.4% year-over-year to $21.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.9 billion (up 14.4% YoY) and the FY2025 annual result came in at $21.9 billion, up 14.4% from the prior year.
- Accumulated Depreciation & Amortization climbed to $21.9 billion in Q4 2025 per MRK's latest filing, from $19.2 billion in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $21.9 billion in Q4 2025 and bottomed at $5.0 million in Q4 2022.
- The 5-year median for Accumulated Depreciation & Amortization is $9.5 billion (2021), against an average of $10.1 billion.
- The widest annual swing landed in 2021, when Accumulated Depreciation & Amortization slipped 8.19%; it then surged 365220.0% in 2023.
- Tracing MRK's Accumulated Depreciation & Amortization over 5 years: stood at $673.0 million in 2021, then slumped by 99.26% to $5.0 million in 2022, then surged by 365220.0% to $18.3 billion in 2023, then advanced by 4.87% to $19.2 billion in 2024, then gained by 14.4% to $21.9 billion in 2025.
- Per Business Quant, the three latest MRK Accumulated Depreciation & Amortization figures stand at $21.9 billion (Q4 2025), $19.2 billion (Q4 2024), and $18.3 billion (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.91 Bn |
| Dec 31, 2025 | 21.91 Bn |
| Dec 31, 2024 | 19.16 Bn |
| Dec 31, 2024 | 19.16 Bn |
| Dec 31, 2023 | 18.27 Bn |
| Dec 31, 2023 | 18.27 Bn |
| Dec 31, 2022 | 5.00 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Jun 30, 2021 | 673.00 Mn |
| Jun 30, 2021 | 673.00 Mn |
| Mar 31, 2021 | 358.00 Mn |
| Mar 31, 2021 | 358.00 Mn |
| Dec 31, 2020 | 6.00 Mn |
| Dec 31, 2020 | 6.00 Mn |
| Sep 30, 2020 | 395.00 Mn |
| Sep 30, 2020 | 395.00 Mn |
| Jun 30, 2020 | 733.00 Mn |
| Jun 30, 2020 | 733.00 Mn |
| Mar 31, 2020 | 377.00 Mn |
| Mar 31, 2020 | 377.00 Mn |
| Dec 31, 2019 | 9.00 Mn |
| Dec 31, 2019 | 9.00 Mn |
| Sep 30, 2019 | 2.72 Bn |
| Sep 30, 2019 | 2.72 Bn |
| Jun 30, 2019 | 427.00 Mn |
| Jun 30, 2019 | 427.00 Mn |
| Mar 31, 2019 | 898.00 Mn |
| Mar 31, 2019 | 898.00 Mn |
| Dec 31, 2018 | 503.00 Mn |
| Dec 31, 2018 | 503.00 Mn |
| Sep 30, 2018 | 324.00 Mn |
| Sep 30, 2018 | 324.00 Mn |
| Jun 30, 2018 | 332.00 Mn |
| Jun 30, 2018 | 332.00 Mn |
| Mar 31, 2018 | 1.14 Bn |
| Mar 31, 2018 | 1.14 Bn |
| Dec 31, 2017 | 4.68 Bn |
| Dec 31, 2017 | 4.68 Bn |
| Sep 30, 2017 | 334.00 Mn |
| Sep 30, 2017 | 334.00 Mn |
| Jun 30, 2017 | 2.36 Bn |
| Jun 30, 2017 | 2.36 Bn |
| Mar 31, 2017 | 1.19 Bn |
| Mar 31, 2017 | 1.19 Bn |
| Dec 31, 2016 | 5.47 Bn |
| Dec 31, 2016 | 5.47 Bn |
| Sep 30, 2016 | 4.29 Bn |
| Sep 30, 2016 | 4.29 Bn |
| Jun 30, 2016 | 438.00 Mn |
| Jun 30, 2016 | 438.00 Mn |
| Mar 31, 2016 | 1.56 Bn |
| Mar 31, 2016 | 1.56 Bn |
| Dec 31, 2015 | 6.38 Bn |
| Dec 31, 2015 | 6.38 Bn |
| Sep 30, 2015 | 381.00 Mn |
| Sep 30, 2015 | 381.00 Mn |
| Jun 30, 2015 | 393.00 Mn |
| Jun 30, 2015 | 393.00 Mn |
| Mar 31, 2015 | 1.64 Bn |
| Mar 31, 2015 | 1.64 Bn |
| Dec 31, 2014 | 6.69 Bn |
| Dec 31, 2014 | 6.69 Bn |
| Sep 30, 2014 | 595.00 Mn |
| Sep 30, 2014 | 595.00 Mn |
| Jun 30, 2014 | 681.00 Mn |
| Jun 30, 2014 | 681.00 Mn |
| Mar 31, 2014 | 1.75 Bn |
| Mar 31, 2014 | 1.75 Bn |
| Dec 31, 2013 | 6.99 Bn |
| Dec 31, 2013 | 6.99 Bn |
| Sep 30, 2013 | 5.03 Bn |
| Sep 30, 2013 | 5.03 Bn |
| Jun 30, 2013 | 458.00 Mn |
| Jun 30, 2013 | 458.00 Mn |
| Mar 31, 2013 | 1.67 Bn |
| Mar 31, 2013 | 1.67 Bn |
| Dec 31, 2012 | 6.98 Bn |
| Dec 31, 2012 | 6.98 Bn |
| Sep 30, 2012 | 477.00 Mn |
| Sep 30, 2012 | 477.00 Mn |
| Jun 30, 2012 | 3.59 Bn |
| Jun 30, 2012 | 3.59 Bn |
| Mar 31, 2012 | 1.79 Bn |
| Mar 31, 2012 | 1.79 Bn |
| Dec 31, 2011 | 7.43 Bn |
| Dec 31, 2011 | 7.43 Bn |
| Sep 30, 2011 | 619.00 Mn |
| Sep 30, 2011 | 619.00 Mn |
| Jun 30, 2011 | 623.00 Mn |
| Jun 30, 2011 | 623.00 Mn |
| Mar 31, 2011 | 1.83 Bn |
| Mar 31, 2011 | 1.83 Bn |
| Dec 31, 2010 | 7.38 Bn |
| Dec 31, 2010 | 7.38 Bn |
| Sep 30, 2010 | 699.00 Mn |
| Sep 30, 2010 | 699.00 Mn |
| Jun 30, 2010 | 786.00 Mn |
| Jun 30, 2010 | 786.00 Mn |
| Mar 31, 2010 | 1.69 Bn |
| Mar 31, 2010 | 1.69 Bn |
| Dec 31, 2009 | 2.58 Bn |
| Dec 31, 2009 | 2.58 Bn |
| Sep 30, 2009 | 371.10 Mn |
| Sep 30, 2009 | 371.10 Mn |
| Jun 30, 2009 | 466.20 Mn |
| Jun 30, 2009 | 466.20 Mn |
| Mar 31, 2009 | 443.30 Mn |
| Mar 31, 2009 | 443.30 Mn |